Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility
June 14, 2021
×
The regulator had inspected the Lupin Somerset site from September 10, 2020 to November 5, 2020
Shares of drug major Lupin fell nearly 3 per cent during the morning trade on Monday after the company received a warning letter from the US FDA for its Somerset, New Jersey facility.
At 11:29 am, Lupin was trading at ₹1194.60 on the BSE, down ₹35.65 or 2.90 per cent. It had opened at ₹1194.00 as against the previous close of ₹1230.25. It hit an intraday high of ₹1202.10 and a low of ₹1173.35.
ON the NSE, it was trading at ₹1,194.50, down ₹35.85 or 2.91 per cent.